Third Party Manufacture. Allergan may perform the Manufacture of Licensed Compounds or Licensed Products through one or more Third Party manufacturers, provided that (a) Allergan remains responsible for such Third Party manufacturer; (b) the Third Party manufacturer undertakes in writing obligations of confidentiality and non-use regarding Confidential Information that are no less protective than those set forth in Article 12, and (c) the Third Party manufacturer agrees in writing to assign or license to Allergan all intellectual property developed in the course of performing any such Manufacture to the extent relating to the Licensed Compound or Licensed Product.
Third Party Manufacture. TANABE may sub-contract any work relating to the manufacture of the BULK DRUG SUBSTANCE, provided, however, the manufacturing so sub-contracted shall be subject to the same terms and conditions as recited herein including but not limited to the right to audit the Records and inspect facilities. VIVUS shall have the right to approve such sub-contractor prior 43 to the selection, in case such sub-contracting is related to the final stage of the manufacture of the BULK DRUG SUBSTANCE, which approval shall not be unreasonably withheld or delayed.
Third Party Manufacture. The second sentence of Section 2.4(c) Manufacturing of the Agreement is hereby changed and replaced with the following: “In the event that Histogenics intends to have a third party manufacture XX0, Xxxxxxxxxxx shall ****.”
Third Party Manufacture. If ATS, or an Affiliate of ATS, does not elect to manufacture a given Subject Product as set forth in Section 4.1 (“ATS Rights to Manufacture”), then either (i) IMDC may elect to manufacture said Subject Product; or (ii) ATS and IMDC shall mutually agree as to a third party manufacturer for said Subject Product.
Third Party Manufacture. Amgen may perform the Manufacture of Licensed Compounds or Licensed Products through one or more Third Party manufacturers, provided that (a) Amgen remains responsible for such Third Party manufacturer performing activities under this Agreement and for any unauthorized use by such Third Party manufacturers of Arrowhead Licensed Technology provided to it by Amgen; (b) the Third Party manufacturer undertakes in writing obligations of confidentiality and non-use regarding Confidential Information that are no less protective than those set forth in Article 12; and (c) the Third Party manufacturer agrees in writing to commercially reasonable terms with respect to the intellectual property relating to such Licensed Compound or Licensed Product.
Third Party Manufacture. In the event that ATS elects not to manufacture one or more Subject Product, the ATS and IMDC will jointly ensure that the party who conducts the manufacturing process for such Subject Products(s) accepts responsibility for its own defects and negligence.
Third Party Manufacture. In the event that LICENSOR elects not to manufacture the LICENSED PRODUCT, then LICENSOR and LICENSEE will jointly ensure that the party who conducts the manufacturing process for such LICENSED PRODUCTS accepts responsibility for its own defects and negligence.
Third Party Manufacture. In the event that the API in the Nanoparticles, the Thin Film or the Product cannot effectively or cost efficiently be manufactured or sourced by either Party, then such manufacturing or sourcing may be contracted by the applicable Party to a Third Party agreed and approved by the Joint Steering Committee.
Third Party Manufacture. Provided that Infineon has enabled the manufacture of Infineon C11FL PRODUCTS in a third party silicon foundry, Actel shall be entitled to have ACTEL PRODUCTS manufactured in such third party silicon foundry, and INFINEON hereby grants Actel a perpetual, irrevocable (except as provided in Sections 12.1, 14.3 and 14.4 below), worldwide, royalty free, non-exclusive, non-transferable (except as provided in Section 15.11 below) right, under all of its IPRs in and to the C11FL TECHNOLOGY and Information to have manufactured Actel PRODUCTS by any third party location at which the Infineon C11FL TECHNOLOGY and process has been or is installed, however such license grant shall be limited to the extent that Infineon has full power and title to make such grant without any third party consent.
Third Party Manufacture. In the event that VERTEX has exercised its Bulk Supply Option with respect to Bulk Drug Substance for a particular Drug Product, VERTEX may engage as a manufacturing subcontractor any Third Party which has a demonstrated ability to deliver high quality pharmaceutical products on a timely basis. VERTEX will notify NOVARTIS of its intention to subcontract to a Third Party not less than sixty (60) days (and earlier if reasonably practicable) prior to concluding a manufacturing arrangement with any such Third Party. If NOVARTIS notifies VERTEX within sixty (60) days after receipt of that notice that NOVARTIS wishes to manufacture the Bulk Drug Substance, VERTEX will provide NOVARTIS with an opportunity to negotiate a mutually agreeable manufacturing agreement before entering into any manufacturing agreement with a Third Party.
